Phenotype variation in human immunodeficiency virus type 1 transmission and disease progression

Disease Markers

Volumn 27, Issue 3-4, 2009, Pages 121-136

  Cavarelli, Mariangela ^a   Scarlatti, Gabriella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Co receptor usage; Disease progression; HIV 1; Transmission; Tropism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RECEPTOR;

CELL GROWTH; DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; VIRUS REPLICATION; VIRUS TRANSMISSION; DISEASE TRANSMISSION; ISOLATION AND PURIFICATION; PATHOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; PHENOTYPE;

EID: 73349093128     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/685608     Document Type: Review

References (183)

1. A.G. Dalgleish, P.C. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves and R.A. Weiss, The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature 312 (1984), 763-767.
2. P.J. Maddon, A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss and R. Axel, The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain, Cell 47 (1986), 333-348.
3. P.J. Maddon, D.R. Littman, M. Godfrey, D.E. Maddon, L. Chess and R. Axel, The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family, Cell 42 (1985), 93-104.
4. P.A. Ashorn, E.A. Berger and B. Moss, Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells, J Virol 64 (1990), 2149-2156. (Pubitemid 20148460)
5. K.A. Page, N.R. Landau and D.R. Littman, Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity, J Virol 64 (1990), 5270-5276.
6. E.A. Berger, HIV entry and tropism: the chemokine receptor connection, AIDS 11 Suppl A (1997), S3-S16.
7. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo and P. Lusso, Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells, Science 270 (1995), 1811-1815.
8. Y. Feng, C.C. Broder, P.E. Kennedy and E.A. Berger, HIV- 1 entry cofactor: functional cDNA cloning of a seventransmembrane, G protein-coupled receptor, Science 272 (1996), 872-877. (Pubitemid 26154590)
9. C.C. Bleul, M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski and T.A. Springer, The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry, Nature 382 (1996), 829-833. (Pubitemid 26299570)
10. E. Oberlin, A. Amara, F. Bachelerie, C. Bessia, J.L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.M. Heard, I. Clark-Lewis, D.F. Legler, M. Loetscher, M. Baggiolini and B. Moser, The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1, Nature 382 (1996), 833-835.
11. C. Combadiere, S.K. Ahuja, H.L. Tiffany and P.M. Murphy, Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP- 1(alpha), MIP-1(beta), and RANTES, J Leukoc Biol 60 (1996), 147-152.
12. M. Samson, O. Labbe, C. Mollereau, G. Vassart and M. Parmentier, Molecular cloning and functional expression of a new human CC-chemokine receptor gene, Biochemistry 35 (1996), 3362-3367. (Pubitemid 26092558)
13. G. Alkhatib, C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy and E.A. Berger, CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1, Science 272 (1996), 1955-1958.
14. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard and J. Sodroski, The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV- 1 isolates, Cell 85 (1996), 1135-1148.
15. H. Deng, R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, C.B. Davis, S.C. Peiper, T.J. Schall, D.R. Littman and N.R. Landau, Identification of a major co-receptor for primary isolates of HIV-1, Nature 381 (1996), 661-666.
16. T. Dragic, V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore and W.A. Paxton, HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5, Nature 381 (1996), 667-673.
17. H. Choe, M. Farzan, M. Konkel, K. Martin, Y. Sun, L. Marcon, M. Cayabyab, M. Berman, M.E. Dorf, N. Gerard, C. Gerard and J. Sodroski, The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1, J Virol 72 (1998), 6113-6118.
18. H.K. Deng, D. Unutmaz, V.N. KewalRamani and D.R. Littman, Expression cloning of new receptors used by simian and human immunodeficiency viruses, Nature 388 (1997), 296-300.
19. B.J. Doranz, J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman and R.W. Doms, A dual-tropic primary HIV-1 isolate that uses fusin and the betachemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors, Cell 85 (1996), 1149-1158.
20. A. Jinno, N. Shimizu, Y. Soda, Y. Haraguchi, T. Kitamura and H. Hoshino, Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection, Biochem Biophys Res Commun 243 (1998), 497-502.
21. S.M. Owen, D. Ellenberger, M. Rayfield, S. Wiktor, P. Michel, M.H. Grieco, F. Gao, B.H. Hahn and R.B. Lal, Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry, J Virol 72 (1998), 5425-5432.
22. B.J. Rollins, Chemokines, Blood 90 (1997), 909-928.
23. M. Samson, A.L. Edinger, P. Stordeur, J. Rucker, V. Verhasselt, M. Sharron, C. Govaerts, C. Mollereau, G.Vassart, R.W. Doms and M. Parmentier, ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains, Eur J Immunol 28 (1998), 1689-1700.
24. B. Asjo, L. Morfeldt-Manson, J. Albert, G. Biberfeld, A. Karlsson, K. Lidman and E.M. Fenyo, Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection, Lancet 2 (1986), 660-662.
25. S. Gartner, P. Markovits, D.M. Markovitz, M.H. Kaplan, R.C. Gallo and M. Popovic, The role of mononuclear phagocytes in HTLV-III/LAV infection, Science 233 (1986), 215-219.
26. M. Tersmette, R.E. de Goede, B.J. Al, I.N. Winkel, R.A. Gruters, H.T. Cuypers, H.G. Huisman and F. Miedema, Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytiuminducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, J Virol 62 (1988), 2026-2032.
27. T.L. Hoffman and R.W. Doms, HIV-1 envelope determinants for cell tropism and chemokine receptor use, Mol Membr Biol 16 (1999), 57-65.
28. E.A. Berger, R.W. Doms, E.M. Fenyo, B.T. Korber, D.R. Littman, J.P. Moore, Q.J. Sattentau, H. Schuitemaker, J. Sodroski and R.A. Weiss, A new classification for HIV-1, Nature 391 (1998), 240.
29. I. Karlsson, L. Antonsson, Y. Shi, M. Oberg, A. Karlsson, J. Albert, B. Olde, C. Owman, M. Jansson and E.M. Fenyo, Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype, J Virol 78 (2004), 11807-11815.
30. A. McKnight, M.T. Dittmar, J. Moniz-Periera, K. Ariyoshi, J.D. Reeves, S. Hibbitts, D. Whitby, E. Aarons, A.E. Proudfoot, H. Whittle and P.R. Clapham, A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4, J Virol 72 (1998), 4065-4071.
31. A. Valentin, H. Trivedi, W. Lu, L.G. Kostrikis and G.N. Pavlakis, CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages, Virology 269 (2000), 294-304.
32. Y. Yi, S. Rana, J.D. Turner, N. Gaddis and R.G. Collman, CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1, J Virol 72 (1998), 772-777.
33. G. Alkhatib, C.C. Broder and E.A. Berger, Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages, J Virol 70 (1996), 5487-5494.
34. R.I. Connor, W.A. Paxton, K.E. Sheridan and R.A. Koup, Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1, J Virol 70 (1996), 8758-8764.
35. R.A. Fouchier, M. Brouwer, N.A. Kootstra, H.G. Huisman and H. Schuitemaker, HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle, J Clin Invest 94 (1994), 1806-1814.
36. J.C. Grivel, M.L. Penn, D.A. Eckstein, B. Schramm, R.F. Speck, N.W. Abbey, B. Herndier, L. Margolis and M.A. Goldsmith, Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue, J Virol 74 (2000), 5347-5351.
37. H.M. Naif, S. Li, M. Alali, A. Sloane, L. Wu, M. Kelly, G. Lynch, A. Lloyd and A.L. Cunningham, CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection, J Virol 72 (1998), 830-836.
38. L. Wu, W.A. Paxton, N. Kassam, N. Ruffing, J.B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R.A. Koup and C.R. Mackay, CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro, J Exp Med 185 (1997), 1681-1691.
39. C. Cheng-Mayer, R. Liu, N.R. Landau and L. Stamatatos, Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor, J Virol 71 (1997), 1657-1661.
40. M.T. Dittmar, A. McKnight, G. Simmons, P.R. Clapham, R.A.Weiss and P. Simmonds, HIV-1 tropism and co-receptor use, Nature 385 (1997), 495-496.
41. E. Karita, J.N. Nkengasong, B. Willems, G. Vanham, K. Fransen, L. Heyndrickx, W. Janssens, P. Piot and G. van der Groen, Macrophage-tropism of HIV-1 isolates of different genetic subtypes, AIDS 11 (1997), 1303-1304.
42. H. Schuitemaker, N.A. Kootstra, R.E. de Goede, F. de Wolf, F. Miedema and M. Tersmette, Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture, J Virol 65 (1991), 356-363.
43. S.L. Kozak, E.J. Platt, N. Madani, F.E. Ferro, Jr., K. Peden and D. Kabat, CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1, J Virol 71 (1997), 873-882.
44. E.J. Platt, K.Wehrly, S.E. Kuhmann, B. Chesebro and D. Kabat, Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1, J Virol 72 (1998), 2855-2864.
45. D.S. Dimitrov, D. Norwood, T.S. Stantchev, Y. Feng, X. Xiao and C.C. Broder, A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages, Virology 259 (1999), 1-6.
46. K. Tokunaga, M.L. Greenberg, M.A. Morse, R.I. Cumming, H.K. Lyerly and B.R. Cullen, Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates, J Virol 75 (2001), 6776-6785.
47. G. Simmons, D. Wilkinson, J.D. Reeves, M.T. Dittmar, S. Beddows, J.Weber, G. Carnegie, U. Desselberger, P.W. Gray, R.A. Weiss and P.R. Clapham, Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry, J Virol 70 (1996), 8355-8360.
48. A. Valentin, J. Albert, E.M. Fenyo and B. Asjo, Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates, J Virol 68 (1994), 6684-6689.
49. H.A. Bazan, G. Alkhatib, C.C. Broder and E.A. Berger, Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates, J Virol 72 (1998), 4485-4491.
50. R.G. Collman and Y. Yi, Cofactors for human immunodeficiency virus entry into primary macrophages, J Infect Dis 179 Suppl 3 (1999), S422-S426.
51. F. Baribaud and R.W. Doms, The impact of chemokine receptor conformational heterogeneity on HIV infection, Cell Mol Biol (Noisy-le-grand) 47 (2001), 653-660.
52. J.W. Balliet, D.L. Kolson, G. Eiger, F.M. Kim, K.A. Mc- Gann, A. Srinivasan and R. Collman, Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate, Virology 200 (1994), 623-631.
53. D. Gabuzda, J. He, A. Ohagen and A.V. Vallat, Chemokine receptors in HIV-1 infection of the central nervous system, Semin Immunol 10 (1998), 203-213.
54. M. Kawamura, T. Ishizaki, A. Ishimoto, T. Shioda, T. Kitamura and A. Adachi, Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures, J Gen Virol 75 (Pt 9) (1994), 2427-2431.
55. C.H. Casper, P. Clevestig, E. Carlenor, T. Leitner, B. Anzen, K. Lidman, E. Belfrage, J. Albert, A.B. Bohlin, L. Naver, S. Lindgren, E.M. Fenyo and A.C. Ehrnst, Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child, J Infect Dis 186 (2002), 914-921.
56. R.N. Husson, Y. Lan, E. Kojima, D. Venzon, H. Mitsuya and K. McIntosh, Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype, J Pediatr 126 (1995), 865-871.
57. L. Ometto, C. Zanotto, A. Maccabruni, D. Caselli, D. Truscia, C. Giaquinto, E. Ruga, L. Chieco-Bianchi and A. De Rossi, Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission, AIDS 9 (1995), 427-434.
58. G. Scarlatti, V. Hodara, P. Rossi, L. Muggiasca, A. Bucceri, J. Albert and E.M. Fenyo, Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype, Virology 197 (1993), 624-629.
59. C. Tscherning-Casper, D. Vodros, E. Menu, K. Aperia, R. Fredriksson, G. Dolcini, G. Chaouat, F. Barre-Sinoussi, J. Albert and E.M. Fenyo, Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1, J Acquir Immune Defic Syndr 24 (2000), 1-9.
60. A.B. van't Wout, N.A. Kootstra, G.A. Mulder-Kampinga, N. Albrecht-van Lent, H.J. Scherpbier, J. Veenstra, K. Boer, R.A. Coutinho, F. Miedema and H. Schuitemaker, Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission, J Clin Invest 94 (1994), 2060-2067.
61. T. Zhu, H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup and D.D. Ho, Genotypic and phenotypic characterization of HIV-1 patients with primary infection, Science 261 (1993), 1179-1181.
62. A. De Rossi, L. Ometto, S. Masiero, M. Zanchetta and L. Chieco-Bianchi, Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection, Acta Paediatr Suppl 421 (1997), 22-28.
63. E.M. Long, S.M. Rainwater, L. Lavreys, K. Mandaliya and J. Overbaugh, HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus, AIDS Res Hum Retroviruses 18 (2002), 567-576.
64. S. Ayehunie, E.A. Garcia-Zepeda, J.A. Hoxie, R. Horuk, T.S. Kupper, A.D. Luster and R.M. Ruprecht, Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors, Blood 90 (1997), 1379-1386.
65. M.T. Dittmar, G. Simmons, S. Hibbitts, M. O'Hare, S. Louisirirotchanakul, S. Beddows, J. Weber, P.R. Clapham and R.A. Weiss, Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups, J Virol 71 (1997), 8008-8013.
66. A. Granelli-Piperno, B. Moser, M. Pope, D. Chen, Y. Wei, F. Isdell, U. O'Doherty, W. Paxton, R. Koup, S. Mojsov, N. Bhardwaj, I. Clark-Lewis, M. Baggiolini and R.M. Steinman, Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors, J Exp Med 184 (1996), 2433-2438.
67. A. Rubbert, C. Combadiere, M. Ostrowski, J. Arthos, M. Dybul, E. Machado, M.A. Cohn, J.A. Hoxie, P.M. Murphy, A.S. Fauci and D.Weissman, Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry, J Immunol 160 (1998), 3933-3941.
68. M. Zaitseva, A. Blauvelt, S. Lee, C.K. Lapham, V. Klaus- Kovtun, H. Mostowski, J. Manischewitz and H. Golding, Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection, Nat Med 3 (1997), 1369-1375.
69. A.I. Spira, P.A. Marx, B.K. Patterson, J. Mahoney, R.A. Koup, S.M. Wolinsky and D.D. Ho, Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques, J Exp Med 183 (1996), 215-225.
70. P. Cameron, M. Pope, A. Granelli-Piperno and R.M. Steinman, Dendritic cells and the replication of HIV-1, J Leukoc Biol 59 (1996), 158-171.
71. T.B. Geijtenbeek, D.S. Kwon, R. Torensma, S.J. van Vliet, G.C. van Duijnhoven, J. Middel, I.L. Cornelissen, H.S. Nottet, V.N. KewalRamani, D.R. Littman, C.G. Figdor and Y. van Kooyk, DC-SIGN, a dendritic cell-specific HIV-1- binding protein that enhances trans-infection of T cells, Cell 100 (2000), 587-597.
72. R.P. van Rij, H. Blaak, J.A. Visser, M. Brouwer, R. Rientsma, S. Broersen, A.M. de Roda Husman and H. Schuitemaker, Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytiuminducing HIV-1, J Clin Invest 106 (2000), 1569.
73. H. Blaak, A.B. van't Wout, M. Brouwer, B. Hooibrink, E. Hovenkamp and H. Schuitemaker, In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline, Proc Natl Acad Sci USA 97 (2000), 1269-1274.
74. C.C. Bleul, L.Wu, J.A. Hoxie, T.A. Springer and C.R. Mackay, The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes, Proc Natl Acad Sci U S A 94 (1997), 1925-1930.
75. M.A. Ostrowski, T.W. Chun, S.J. Justement, I. Motola, M.A. Spinelli, J. Adelsberger, L.A. Ehler, S.B. Mizell, C.W. Hallahan and A.S. Fauci, Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals, J Virol 73 (1999), 6430-6435.
76. J.M. Brenchley, T.W. Schacker, L.E. Ruff, D.A. Price, J.H. Taylor, G.J. Beilman, P.L. Nguyen, A. Khoruts, M. Larson, A.T. Haase and D.C. Douek, CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract, J Exp Med 200 (2004), 749-759.
77. S. Mehandru, M.A. Poles, K. Tenner-Racz, A. Horowitz, A. Hurley, C. Hogan, D. Boden, P. Racz and M. Markowitz, Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract, J Exp Med 200 (2004), 761-770.
78. R.S. Veazey, M. DeMaria, L.V. Chalifoux, D.E. Shvetz, D.R. Pauley, H.L. Knight, M. Rosenzweig, R.P. Johnson, R.C. Desrosiers and A.A. Lackner, Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection, Science 280 (1998), 427-431.
79. M.K. Jenkins, A. Khoruts, E. Ingulli, D.L. Mueller, S.J. McSorley, R.L. Reinhardt, A. Itano and K.A. Pape, In vivo activation of antigen- specificCD4Tcells, Annu Rev Immunol 19 (2001), 23-45.
80. M.I. Bukrinsky, T.L. Stanwick, M.P. Dempsey and M. Stevenson, Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection, Science 254 (1991), 423-427.
81. J.A. Zack, S.J. Arrigo, S.R. Weitsman, A.S. Go, A. Haislip and I.S. Chen, HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure, Cell 61 (1990), 213-222.
82. J.A. Zack, A.M. Haislip, P. Krogstad and I.S. Chen, Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle, J Virol 66 (1992), 1717-1725.
83. W.W. Agace, A. Amara, A.I. Roberts, J.L. Pablos, S. Thelen, M. Uguccioni, X.Y. Li, J. Marsal, F. Arenzana-Seisdedos, T. Delaunay, E.C. Ebert, B. Moser and C.M. Parker, Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation, Curr Biol 10 (2000), 325-328.
84. B.K. Patterson, A. Landay, J. Andersson, C. Brown, H. Behbahani, D. Jiyamapa, Z. Burki, D. Stanislawski, M.A. Czerniewski and P. Garcia, Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission, Am J Pathol 153 (1998), 481-490. (Pubitemid 28373659)
85. J.B. Rottman, K.P. Ganley, K. Williams, L. Wu, C.R. Mackay and D.J. Ringler, Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection, Am J Pathol 151 (1997), 1341-1351.
86. T.N. Kledal, M.M. Rosenkilde, F. Coulin, G. Simmons, A.H. Johnsen, S. Alouani, C.A. Power, H.R. Luttichau, J. Gerstoft, P.R. Clapham, I. Clark-Lewis, T.N. Wells and T.W. Schwartz, A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus, Science 277 (1997), 1656-1659.
87. P.D. Bieniasz, R.A. Fridell, I. Aramori, S.S. Ferguson, M.G. Caron and B.R. Cullen, HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor, EMBO J 16 (1997), 2599-2609.
88. L. Picard, G. Simmons, C.A. Power, A. Meyer, R.A. Weiss and P.R. Clapham, Multiple extracellular domains of CCR- 5 contribute to human immunodeficiency virus type 1 entry and fusion, J Virol 71 (1997), 5003-5011. (Pubitemid 27258170)
89. T. Dragic, A. Trkola, S.W. Lin, K.A. Nagashima, F. Kajumo, L. Zhao, W.C. Olson, L. Wu, C.R. Mackay, G.P. Allaway, T.P. Sakmar, J.P. Moore and P.J. Maddon, Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry, J Virol 72 (1998), 279-285.
90. P. Trivedi, D. Horejsh, S.B. Hinds, P.W. Hinds, II, M.S. Wu, M.S. Salvato and C.D. Pauza, Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia, J Virol 70 (1996), 6876-6883.
91. T. Zhu, N. Wang, A. Carr, D.S. Nam, R. Moor-Jankowski, D.A. Cooper and D.D. Ho, Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission, J Virol 70 (1996), 3098-3107.
92. D.S. Callaway, R.M. Ribeiro and M.A. Nowak, Virus phenotype switching and disease progression in HIV-1 infection, Proc Biol Sci 266 (1999), 2523-2530.
93. M. Cornelissen, G. Mulder-Kampinga, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. van der Hoek, C. Sol, R. Coutinho and et al., Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population, J Virol 69 (1995), 1810-1818.
94. J.L. Lathey, R.D. Pratt and S.A. Spector, Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1, J Infect Dis 175 (1997), 231-232.
95. D.C. Montefiori, R.G. Collman, T.R. Fouts, J.Y. Zhou, M. Bilska, J.A. Hoxie, J.P. Moore and D.P. Bolognesi, Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage, J Virol 72 (1998), 1886-1893.
96. A. Trkola, T. Ketas, V.N. Kewalramani, F. Endorf, J.M. Binley, H. Katinger, J. Robinson, D.R. Littman and J.P. Moore, Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage, J Virol 72 (1998), 1876-1885.
97. A. Karlsson, K. Parsmyr, E. Sandstrom, E.M. Fenyo and J. Albert, MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection, J Clin Microbiol 32 (1994), 364-370. (Pubitemid 24033896)
98. M.Koot, I.P.Keet, A.H.Vos, R.E. de Goede, M.T. Roos, R.A. Coutinho, F. Miedema, P.T. Schellekens and M. Tersmette, Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS, Ann Intern Med 118 (1993), 681-688.
99. M. Tersmette, R.A. Gruters, F. de Wolf, R.E. de Goede, J.M. Lange, P.T. Schellekens, J. Goudsmit, H.G. Huisman and F. Miedema, Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates, J Virol 63 (1989), 2118-2125.
100. M.D. Hazenberg, J.W. Stuart, S.A. Otto, J.C. Borleffs, C.A. Boucher, R.J. de Boer, F. Miedema and D. Hamann, T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART), Blood 95 (2000), 249-255.
101. C. Casper, L. Naver, P. Clevestig, E. Belfrage, T. Leitner, J. Albert, S. Lindgren, C. Ottenblad, A.B. Bohlin, E.M. Fenyo and A. Ehrnst, Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes, AIDS Res Hum Retroviruses 18 (2002), 343-352.
102. J.R. Fiore, A. Bjorndal, K.A. Peipke, M. Di Stefano, G. Angarano, G. Pastore, H. Gaines, E.M. Fenyo and J. Albert, The biological phenotype of HIV-1 is usually retained during and after sexual transmission, Virology 204 (1994), 297-303.
103. G. Scarlatti, E. Tresoldi, A. Bjorndal, R. Fredriksson, C. Colognesi, H.K. Deng, M.S. Malnati, A. Plebani, A.G. Siccardi, D.R. Littman, E.M. Fenyo and P. Lusso, In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokinemediated suppression, Nat Med 3 (1997), 1259-1265.
104. X.F. Yu, Z.Wang, D. Vlahov, R.B. Markham, H. Farzadegan and J.B. Margolick, Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users, J Infect Dis 178 (1998), 388-396.
105. R.I. Connor and D.D. Ho, Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression, J Virol 68 (1994), 4400-4408.
106. R.I. Connor, H. Mohri, Y. Cao and D.D. Ho, Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals, J Virol 67 (1993), 1772-1777.
107. R.A. Fouchier, L.Meyaard, M. Brouwer, E. Hovenkamp and H. Schuitemaker, Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo, Virology 219 (1996), 87-95.
108. A.B. van't Wout, L.J. Ran, C.L. Kuiken, N.A. Kootstra, S.T. Pals and H. Schuitemaker, Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy, J Virol 72 (1998), 488-496.
109. R. Correa and M.A. Munoz-Fernandez, Viral phenotype affects the thymic production of new T cells in HIV-1-infected children, AIDS 15 (2001), 1959-1963.
110. M.B. Zaitseva, S. Lee, R.L. Rabin, H.L. Tiffany, J.M. Farber, K.W. Peden, P.M. Murphy and H. Golding, CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection, J Immunol 161 (1998), 3103-3113.
111. M.D. Hazenberg, S.A. Otto, D. Hamann, M.T. Roos, H. Schuitemaker, R.J. de Boer and F. Miedema, Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation, AIDS 17 (2003), 1419-1424.
112. R.R. Regoes and S. Bonhoeffer, The HIV coreceptor switch: a population dynamical perspective, Trends Microbiol 13 (2005), 269-277.
113. M. Mild, J. Esbjornsson, E.M. Fenyo and P. Medstrand, Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch, J Virol 81 (2007), 3369-3376.
114. T. Cilliers, J. Nhlapo, M. Coetzer, D. Orlovic, T. Ketas, W.C. Olson, J.P. Moore, A. Trkola and L. Morris, The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C, J Virol 77 (2003), 4449-4456.
115. M. Coetzer, T. Cilliers, M. Papathanasopoulos, G. Ramjee, S.A. Karim, C.Williamson and L. Morris, Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa, AIDS Res Hum Retroviruses 23 (2007), 316-321.
116. J. Repits, M. Oberg, J. Esbjornsson, P. Medstrand, A. Karlsson, J. Albert, E.M. Fenyo and M. Jansson, Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency, J Gen Virol 86 (2005), 2859-2869.
117. M. Jansson, E. Backstrom, A. Bjorndal, V. Holmberg, P. Rossi, E.M. Fenyo, M. Popovic, J. Albert and H. Wigzell, Coreceptor usage and RANTES sensitivity of nonsyncytium- inducing HIV-1 isolates obtained from patients with AIDS, J Hum Virol 2 (1999), 325-338.
118. F.A. Koning, D. Kwa, B. Boeser-Nunnink, J. Dekker, J. Vingerhoed, H. Hiemstra and H. Schuitemaker, Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection, J Infect Dis 188 (2003), 864-872.
119. L. Gray, J. Sterjovski, M. Churchill, P. Ellery, N. Nasr, S.R. Lewin, S.M. Crowe, S.L.Wesselingh, A.L. Cunningham and P.R. Gorry, Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome, Virology 337 (2005), 384-398.
120. R. Liu, W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A.Koup and N.R. Landau, Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection, Cell 86 (1996), 367-377.
121. J.J. Martinson, N.H. Chapman, D.C. Rees, Y.T. Liu and J.B. Clegg, Global distribution of the CCR5 gene 32-basepair deletion, Nat Genet 16 (1997), 100-103.
122. S. Rana, G. Besson, D.G. Cook, J. Rucker, R.J. Smyth, Y. Yi, J.D. Turner, H.H. Guo, J.G. Du, S.C. Peiper, E. Lavi, M. Samson, F. Libert, C. Liesnard, G. Vassart, R.W. Doms, M. Parmentier and R.G. Collman, Role of CCR5 in infection of primary macrophages and lymphocytes by macrophagetropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation, J Virol 71 (1997), 3219-3227.
123. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels and S.J. O'Brien, Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, Science 273 (1996), 1856-1862.
124. Y. Huang, W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N.R. Landau, J. Phair, D.D. Ho and R.A. Koup, The role of a mutant CCR5 allele in HIV-1 transmission and disease progression, Nat Med 2 (1996), 1240-1243.
125. S. Philpott, H. Burger, T. Charbonneau, R. Grimson, S.H. Vermund, A. Visosky, S. Nachman, A. Kovacs, P. Tropper, H. Frey and B. Weiser, CCR5 genotype and resistance to vertical transmission of HIV-1, J Acquir Immune Defic Syndr 21 (1999), 189-193.
126. M. Samson, F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R.J. Smyth, R.G. Collman, R.W. Doms, G. Vassart and M. Parmentier, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature 382 (1996), 722-725.
127. D.A.Wilkinson, E.A. Operskalski, M.P. Busch, J.W. Mosley and R.A. Koup, A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness, J Infect Dis 178 (1998), 1163-1166.
128. R. Biti, R. Ffrench, J. Young, B. Bennetts, G. Stewart and T. Liang, HIV-1 infection in an individual homozygous for the CCR5 deletion allele, Nat Med 3 (1997), 252-253.
129. N.L. Michael, J.A. Nelson, V.N. KewalRamani, G. Chang, S.J. O'Brien, J.R. Mascola, B. Volsky, M. Louder, G.C. White, 2nd, D.R. Littman, R. Swanstrom and T.R. O'Brien, Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32, J Virol 72 (1998), 6040-6047.
130. H.W. Sheppard, C. Celum, N.L. Michael, S. O'Brien, M. Dean, M. Carrington, D. Dondero and S.P. Buchbinder, HIV- 1 infection in individuals with
131. I. Theodorou, L. Meyer, M. Magierowska, C. Katlama and C. Rouzioux, HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group, Lancet 349 (1997), 1219-1220.
132. J. Eugen-Olsen, A.K. Iversen, P. Garred, U. Koppelhus, C. Pedersen, T.L. Benfield, A.M. Sorensen, T. Katzenstein, E. Dickmeiss, J. Gerstoft, P. Skinhoj, A. Svejgaard, J.O. Nielsen and B. Hofmann, Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals, AIDS 11 (1997), 305-310.
133. N.L. Michael, L.G. Louie, A.L. Rohrbaugh, K.A. Schultz, D.E. Dayhoff, C.E. Wang and H.W. Sheppard, The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression, Nat Med 3 (1997), 1160-1162.
134. P.A. Zimmerman, A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Combadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, M. Vaccarezza, P.E. Kennedy, V. Kumaraswami, J.V. Giorgi, R. Detels, J. Hunter, M. Chopek, E.A. Berger, A.S. Fauci, T.B. Nutman and P.M. Murphy, Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk, Mol Med 3 (1997), 23-36.
135. T.L. Hoffman, R.R. MacGregor, H. Burger, R. Mick, R.W. Doms and R.G. Collman, CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status, J Infect Dis 176 (1997), 1093-1096.
136. C.W. Mandl, S.W. Aberle, J.H. Henkel, E. Puchhammer- Stockl and F.X. Heinz, Possible influence of the mutantCCR5 Allele on vertical transmission of HIV-1, J Med Virol 55 (1998), 51-55.
137. P. Garred, Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis? Lancet 351 (1998), 2-3.
138. L. Meyer, M. Magierowska, J.B. Hubert, C. Rouzioux, C. Deveau, F. Sanson, P. Debre, J.F. Delfraissy and I. Theodorou, Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group, AIDS 11 (1997), F73-F78.
139. T.L. Katzenstein, J. Eugen-Olsen, B. Hofmann, T. Benfield, C. Pedersen, A.K. Iversen, A.M. Sorensen, P. Garred, U. Koppelhus, A. Svejgaard and J. Gerstoft, HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group, J Acquir Immune Defic Syndr Hum Retrovirol 16 (1997), 10-14.
140. R.E. Edelstein, L.A. Arcuino, J.P. Hughes, A.J. Melvin, K.M. Mohan, P.D. King, C.L. McLellan, B.L. Murante, B.P. Kassman and L.M. Frenkel, Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes, J Acquir Immune Defic Syndr Hum Retrovirol 16 (1997), 243-246.
141. A. Mangano, F. Prada, A. Roldan, G. Picchio, R. Bologna and L. Sen, Distribution of CCR-5 delta32 allele in Argentinian children at risk of HIV-1 infection: its role in vertical transmission, AIDS 12 (1998), 109-110.
142. M. Misrahi, J.P. Teglas, N. N'Go, M. Burgard, M.J. Mayaux, C. Rouzioux, J.F. Delfraissy and S. Blanche, CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group, JAMA 279 (1998), 277-280.
143. C.M. Rousseau, J.J. Just, E.J. Abrams, J. Casabona, Z. Stein and M.C. King, CCR5del32 in perinatal HIV-1 infection, J Acquir Immune Defic Syndr Hum Retrovirol 16 (1997), 239-242.
144. W.T. Shearer, L.A. Kalish and P.A. Zimmerman, CCR5 HIV- 1 vertical transmission. Women and Infants Transmission Study Group, J Acquir Immune Defic Syndr Hum Retrovirol 17 (1998), 180-181.
145. M.L. Romiti, C. Colognesi, C. Cancrini, A. Mas, M. Berrino, F. Salvatori, P. Orlandi, M. Jansson, E. Palomba, A. Plebani, J.M. Bertran, M. Hernandez, M. de Martino, A. Amoroso, P.A. Tovo, P. Rossi, T. Espanol and G. Scarlatti, Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection, Mol Med 6 (2000), 28-36.
146. L. Ometto, M. Zanchetta, M. Mainardi, G.L. De Salvo, M.C. Garcia-Rodriguez, L. Gray, M.L. Newell, L. Chieco-Bianchi and A. De Rossi, Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission, AIDS 14 (2000), 1721-1729.
147. V. Boyer, C. Desgranges, M.A. Trabaud, E. Fischer and M.D. Kazatchkine, Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion, J Exp Med 173 (1991), 1151-1158.
148. J.M. Harouse, R.G. Collman and F. Gonzalez-Scarano, Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4- negative, galactosyl ceramide/3' sulfo-galactosyl ceramidepositive cell line, J Virol 69 (1995), 7383-7390.
149. T. Schneider, R. Ullrich and M. Zeitz, The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract, Semin Gastrointest Dis 7 (1996), 19-29.
150. S. Bhat, R.V. Mettus, E.P. Reddy, K.E. Ugen, V. Srikanthan, W.V. Williams and D.B. Weiner, The galactosyl ceramide/ sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275, AIDS Res Hum Retroviruses 9 (1993), 175-181.
151. J.P. Ioannidis, D.G. Contopoulos-Ioannidis, P.S. Rosenberg, J.J. Goedert, A. De Rossi, T. Espanol, L. Frenkel, M.J. Mayaux, M.L. Newell, S.G. Pahwa, C. Rousseau, G. Scarlatti, S. Sei, L. Sen and T.R. O'Brien, Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis, AIDS 17 (2003), 1631-1638.
152. D.H. McDermott, P.A. Zimmerman, F. Guignard, C.A. Kleeberger, S.F. Leitman and P.M. Murphy, CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS), Lancet 352 (1998), 866-870.
153. M.P. Martin, M. Dean, M.W. Smith, C. Winkler, B. Gerrard, N.L. Michael, B. Lee, R.W. Doms, J. Margolick, S. Buchbinder, J.J. Goedert, T.R. O'Brien, M.W. Hilgartner, D. Vlahov, S.J. O'Brien and M. Carrington, Genetic acceleration of AIDS progression by a promoter variant of CCR5, Science 282 (1998), 1907-1911.
154. C. Quillent, E. Oberlin, J. Braun, D. Rousset, G. Gonzalez- Canali, P. Metais, L. Montagnier, J.L.Virelizier, F. Arenzana- Seisdedos and A. Beretta, HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene, Lancet 351 (1998), 14-18.
155. M.A. Ansari-Lari, X.M. Liu, M.L. Metzker, A.R. Rut and R.A. Gibbs, The extent of genetic variation in the CCR5 gene, Nat Genet 16 (1997), 221-222.
156. M. Carrington, M. Dean, M.P. Martin and S.J. O'Brien, Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences, Hum Mol Genet 8 (1999), 1939-1945.
157. O.M. Howard, A.K. Shirakawa, J.A. Turpin, A. Maynard, G.J. Tobin, M. Carrington, J.J. Oppenheim and M. Dean, Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function, J Biol Chem 274 (1999), 16228-16234.
158. M.W. Smith, M. Dean, M. Carrington, C.Winkler, G.A. Huttley, D.A. Lomb, J.J. Goedert, T.R. O'Brien, L.P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov, K. Hoots, M.W. Hilgartner and S.J. O'Brien, Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study, Science 277 (1997), 959-965.
159. A. Mangano, J. Kopka, M. Batalla, R. Bologna and L. Sen, Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection, J Acquir Immune Defic Syndr 23 (2000), 52-57.
160. C. Winkler, W. Modi, M.W. Smith, G.W. Nelson, X.Wu, M. Carrington, M. Dean, T. Honjo, K. Tashiro, D.Yabe, S. Buchbinder, E. Vittinghoff, J.J. Goedert, T.R. O'Brien, L.P. Jacobson, R. Detels, S. Donfield, A.Willoughby, E. Gomperts, D. Vlahov, J. Phair and S.J. O'Brien, Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), Science 279 (1998), 389-393.
161. A. Brambilla, C. Villa, G. Rizzardi, F. Veglia, S. Ghezzi, A. Lazzarin, M. Cusini, S. Muratori, E. Santagostino, A. Gringeri, L.G. Louie, H.W. Sheppard, G. Poli, N.L. Michael, G. Pantaleo and E. Vicenzi, Shorter survival of SDF1- 3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection, J Infect Dis 182 (2000), 311-315.
162. M. Magierowska, I. Theodorou, P. Debre, F. Sanson, B. Autran, Y. Riviere, D. Charron and D. Costagliola, Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals, Blood 93 (1999), 936-941.
163. S. Mummidi, S.S. Ahuja, E. Gonzalez, S.A. Anderson, E.N. Santiago, K.T. Stephan, F.E. Craig, P. O'Connell, V. Tryon, R.A. Clark, M.J. Dolan and S.K. Ahuja, Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression, Nat Med 4 (1998), 786-793.
164. R.P. van Rij, S. Broersen, J. Goudsmit, R.A. Coutinho and H. Schuitemaker, The role of a stromal cell-derived factor- 1 chemokine gene variant in the clinical course of HIV-1 infection, AIDS 12 (1998), F85-F90.
165. G.C. John, C. Rousseau, T. Dong, S. Rowland-Jones, R. Nduati, D. Mbori-Ngacha, T. Rostron, J.K. Kreiss, B.A. Richardson and J. Overbaugh, Maternal SDF1 3'A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission, J Virol 74 (2000), 5736-5739.
166. S. Sei, A.M. Boler, G.T. Nguyen, S.K. Stewart, Q.E.Yang, M. Edgerly, L.V.Wood, P. Brouwers and D.J.Venzon, Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection, AIDS 15 (2001), 1343-1352.
167. E. Tresoldi, M.L. Romiti, M. Boniotto, S. Crovella, F. Salvatori, E. Palomba, A. Pastore, C. Cancrini, M. de Martino, A. Plebani, G. Castelli, P. Rossi, P.A. Tovo, A. Amoroso and G. Scarlatti, Prognostic value of the stromal cell-derived factor 1 3'A mutation in pediatric human immunodeficiency virus type 1 infection, J Infect Dis 185 (2002), 696-700.
168. S. Faure, L. Meyer, D. Costagliola, C. Vaneensberghe, E. Genin, B. Autran, J.F. Delfraissy, D.H. McDermott, P.M. Murphy, P. Debre, I. Theodorou and C. Combadiere, Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1, Science 287 (2000), 2274-2277.
169. K.K. Singh, M.D. Hughes, J. Chen and S.A. Spector, Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load, J Infect Dis 191 (2005), 1971-1980.
170. G. Scarlatti, Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries, AIDS Rev 6 (2004), 67-78.
171. M. Cavarelli, I. Karlsson, M. Zanchetta, L. Antonsson, A. Plebani, C. Giaquinto, E.M. Fenyo, A. De Rossi and G. Scarlatti, HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children, PLoS ONE 3 (2008), e3292.
172. F. Salvatori and G. Scarlatti, HIV type 1 chemokine receptor usage in mother-to-child transmission, AIDS Res Hum Retroviruses 17 (2001), 925-935.
173. D.L. Tuttle, C.R. Coberley, X. Xie, Z.C. Kou, J.W. Sleasman and M.M. Goodenow, Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor ex pression on CD4 T lymphocyte subsets in infants and adolescents, AIDS Res Hum Retroviruses 20 (2004), 305-313.
174. C. Pasquier, C. Cayrou, A. Blancher, C. Tourne-Petheil, A. Berrebi, J. Tricoire, J. Puel and J. Izopet, Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1, J Virol 72 (1998), 8493-8501.
175. S.M. Wolinsky, C.M. Wike, B.T. Korber, C. Hutto, W.P. Parks, L.L. Rosenblum, K.J. Kunstman, M.R. Furtado and J.L. Munoz, Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants, Science 255 (1992), 1134-1137.
176. P. Clevestig, I. Maljkovic, C. Casper, E. Carlenor, S. Lindgren, L. Naver, A.B. Bohlin, E.M. Fenyo, T. Leitner and A. Ehrnst, The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission, AIDS Res Hum Retroviruses 21 (2005), 371-378.
177. C. Ripamonti, T. Leitner, A. Lauren, I. Karlsson, A. Pastore, M. Cavarelli, L. Antonsson, A. Plebani, E.M. Fenyo and G. Scarlatti, Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression, AIDS Res Hum Retroviruses 23 (2007), 1531-1540.
178. D.R. Kuritzkes, HIV-1 entry inhibitors: an overview, Curr Opin HIV AIDS 4 (2009), 82-87.
179. J.P. Moore and D.R. Kuritzkes, A piece de resistance: how HIV-1 escapes small molecule CCR5 inhibitors, Curr Opin HIV AIDS 4 (2009), 118-124.
180. B.J. Doranz, K. Grovit-Ferbas, M.P. Sharron, S.H. Mao, M.B. Goetz, E.S. Daar, R.W. Doms and W.A. O'Brien, A smallmolecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor, J Exp Med 186 (1997), 1395-1400.
181. T. Murakami, T. Nakajima, Y. Koyanagi, K. Tachibana, N. Fujii, H. Tamamura, N. Yoshida, M. Waki, A. Matsumoto, O. Yoshie, T. Kishimoto, N. Yamamoto and T. Nagasawa, A small molecule CXCR4 inhibitor that blocks T cell linetropic HIV-1 infection, J Exp Med 186 (1997), 1389-1393.
182. J.D. Reeves and A.J. Piefer, Emerging drug targets for antiretroviral therapy, Drugs 65 (2005), 1747-1766.
183. G. Hutter, D. Nowak, M. Mossner, S. Ganepola, A. Mussig, K. Allers, T. Schneider, J. Hofmann, C. Kucherer, O. Blau, I.W. Blau, W.K. Hofmann and E. Thiel, Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation, N Engl J Med 360 (2009), 692-698.